GODAVARI DRUGS
Intrinsic Value | Fundamental Analysis

BOM : 530317     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Good [Stock is Cheap]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : NA
May 25,2022
Price(EOD): β‚Ή 67.60
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: β‚Ή 50.70 Cr
Value of β‚Ή 1 Lac invested in GODAVARI DRUGS
on May 25,2017 (price: β‚Ή 39.45)

β‚Ή 1 L

β‚Ή 1.71 L

1W : -1.4% 1M : -5% 1Y : 15%
COMMUNITY POLL
for GODAVARI DRUGS
Please provide your vote to see the results
GODAVARI DRUGS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
GODAVARI DRUGS -1.4% -5% 15%
SUN PHARMACEUTICAL INDUSTRIES 3% 1.3% 31.9%
DIVIS LABORATORIES -16.2% -20.1% -9.3%
DR REDDYS LABORATORIES 9.6% 4.7% -16.9%
CIPLA 3.6% 1.9% 4.7%
GLAND PHARMA -11.4% -16.5% -9.6%
PIRAMAL ENTERPRISES -4.4% -14.3% 4.7%
CADILA HEALTHCARE 8.2% 7.4% -39.9%
TORRENT PHARMACEUTICALS 1.7% -3.5% -4.6%

FUNDAMENTAL ANALYSIS OF GODAVARI DRUGS

 
Fundamentals Score
[ Q(TTM): Mar2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF GODAVARI DRUGS

 
Valuation Score
[As on : May 25,2022 ]

Ratio Standalone
P/E
P/B
P/S
9.7
P/E Calculated based on EPS of 6.97
[ Mar2022 - Standalone Results ]

1.72
P/B Calculated based on Book Value of 39.35
[ Mar2022 - Standalone Results ]

0.31
P/S Calculated based on Revenues of 161.105 Cr
[ TTM - Standalone Results ]

Financial Ratios →

Insights πŸ’‘ GODAVARI DRUGS is one of the potential top 21% undervalued companies ! Discover More →

FAIR VALUE OF GODAVARI DRUGS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
113%
-33%
-26%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF GODAVARI DRUGS


Insights πŸ’‘ There are 5% companies with bullish price momentum currently! Discover More →

GODAVARI DRUGS vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF GODAVARI DRUGS

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.78
1.25
1.36
1.13
-
-
-
-
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF GODAVARI DRUGS

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF GODAVARI DRUGS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
31.17%
4.6%
21.14%
-4.88%
34.35%
5.34%
19.2%
-1.48%
QtrlyTrend
4
Latest Qtr: Mar2022
Quarterly Result Analysis →

Insights πŸ’‘ GODAVARI DRUGS is one of the top 44% companies with good quarterly result uptrend ! Discover More →

GODAVARI DRUGS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about GODAVARI DRUGS


Is GODAVARI DRUGS good for long term investment?

As on May 25,2022, the Fundamentals of GODAVARI DRUGS look Poor and hence it may not be good for long term investment ! See Financial Performance of GODAVARI DRUGS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is GODAVARI DRUGS UnderValued or OverValued?

As on May 25,2022, GODAVARI DRUGS is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of GODAVARI DRUGS ?

As on May 25,2022, the Intrinsic Value of GODAVARI DRUGS is Rs. 91.60 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 31.68
Fair Value [Median EV / Sales Model] : Rs. 100.22
Fair Value [Median Price / Sales Model] : Rs. 91.60
Median Fair Value of GODAVARI DRUGS : Rs. 91.60

Is GODAVARI DRUGS trading at a Premium or Discount?

As on May 25,2022, GODAVARI DRUGS is trading at a Discount of -26% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z